Acura Pharmaceuticals CFO Peter Clemens to retire effective Sept 30; Robert Seiser appointed successor

ACURA PHARMACEUTICALS, INC

Peter Clemens steps down as CFO on July 31, 2024, remains VP through Sept 30 for transition.
Robert A. Seiser, currently VP Treasurer & Corporate Controller since 1998, appointed Sr. VP & CFO effective Aug 1, 2024.
Board approved Clemens's retirement and Seiser's appointment on May 31, 2024.
Clemens will continue as Vice President until end of September to ensure smooth handover.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert A. Seiser

Sr. Vice President and Chief Financial Officer

ACURA PHARMACEUTICALS, INC

Effective: 2024-08-01
Filed: June 4, 2024, 7:59 PM ET

Also on May 31, 2024, Robert A. Seiser was appointed as Sr. Vice President and Chief Financial Officer, effective August 1, 2024.

Role change

Peter A. Clemens

Sr. Vice President and Chief Financial Officer

ACURA PHARMACEUTICALS, INC

Effective: 2024-07-31
Successor: Robert A. Seiser
Filed: June 4, 2024, 7:59 PM ET

Although Mr. Clemens will remain an employee of the Company as Vice President until the end of September to ensure a smooth transition, he is stepping down as Chief Financial Officer, effective July 31, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert A. Seiser was appointed as Sr. Vice President and Chief Financial Officer at ACURA PHARMACEUTICALS, INC.

Action: appointed
Role: Sr. Vice President and Chief Financial Officer

Exact text from the filing

Also on May 31, 2024, Robert A. Seiser was appointed as Sr. Vice President and Chief Financial Officer, effective August 1, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter A. Clemens retired as Sr. Vice President and Chief Financial Officer at ACURA PHARMACEUTICALS, INC.

Action: retired
Role: Sr. Vice President and Chief Financial Officer

Exact text from the filing

Although Mr. Clemens will remain an employee of the Company as Vice President until the end of September to ensure a smooth transition, he is stepping down as Chief Financial Officer, effective July 31, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001104659-24-068092

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.